3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
2
Completed
1
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
8
Prostatic Neoplasms
7
Leukemia, Myeloid, Acute
6
Colorectal Neoplasms
5
Breast Neoplasms
5
Stomach Neoplasms
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Congenital Abnormalities
4
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lung Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Venous Thromboembolism
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Neuroblastoma
2
Neoplasm Metastasis
2
Motor Activity
2
Melanoma
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Interventions
Fluorouracil
12
Radiotherapy
8
Cisplatin
8
pembrolizumab
4
Papillomavirus Vaccines
4
Mitomycin
4
Irinotecan
4
Cyclophosphamide
4
Cetuximab
4
Light Coagulation
3
Interleukin-12 Subunit p35
3
Capecitabine
3
fludarabine phosphate
2
fludarabine
2
atezolizumab
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Trastuzumab
2
Surveys and Questionnaires
2
Radiation
2
Quality of Life
2
Paclitaxel
2
Oxaliplatin
2
Erlotinib Hydrochloride
2
Early Intervention, Educational
2
Carboplatin
2
Biopsy
2
toripalimab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anus Neoplasms
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts